Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA

Specific alterations (mutations, deletions, insertions) of virus genomes are crucial for the functional characterization of their regulatory elements and their expression products, as well as a prerequisite for the creation of attenuated viruses that could serve as vaccine candidates. Virus genome tailoring can be performed either by using traditionally cloned genomes as starting materials, followed by site-directed mutagenesis, or by de novo synthesis of modified virus genomes or parts thereof. A systematic nomenclature for such recombinant viruses is necessary to set them apart from wild-type and laboratory-adapted viruses, and to improve communication and collaborations among researchers who may want to use recombinant viruses or create novel viruses based on them. A large group of filovirus experts has recently proposed nomenclatures for natural and laboratory animal-adapted filoviruses that aim to simplify the retrieval of sequence data from electronic databases. Here, this work is extended to include nomenclature for filoviruses obtained in the laboratory via reverse genetics systems. The previously developed template for natural filovirus genetic variant naming, (/)///-, is retained, but we propose to adapt the type of information added to each field for cDNA clone-derived filoviruses. For instance, the full-length designation of an Ebola virus Kikwit variant rescued from a plasmid developed at the US Centers for Disease Control and Prevention could be akin to “Ebola virus H.sapiens-rec/COD/1995/Kikwit-abc1” (with the suffix “rec” identifying the recombinant nature of the virus and “abc1” being a placeholder for any meaningful isolate designator). Such a full-length designation should be used in databases and the methods section of publications. Shortened designations (such as “EBOV H.sap/COD/95/Kik-abc1”) and abbreviations (such as “EBOV/Kik-abc1”) could be used in the remainder of the text, depending on how critical it is to convey information contained in the full-length name. “EBOV” would suffice if only one EBOV strain/variant/isolate is addressed.

Jens H. Kuhn | Mark S. Lever | Kartik Chandran | Thomas Hoenen | Manfred Weidmann | Peter B. Jahrling | Ayato Takada | John M. Dye | Erica Ollmann Saphire | Robert A. Davey | Sina Bavari | Lisa E. Hensley | Sophie J. Smither | Stephan Becker | Gene G. Olinger | Stuart T. Nichol | Travis K. Warren | Steven B. Bradfute | P. Formenty | J. Dye | J. Gonzalez | K. Chandran | N. Sullivan | R. Davey | G. Olinger | G. Kobinger | A. Takada | V. Volchkov | V. Volchkova | H. Klenk | J. Kuhn | Yīmíng Bào | M. Lackemeyer | S. Radoshitzky | G. Palacios | P. Jahrling | E. Saphire | M. Weidmann | Yíngyún Caì | G. Ignatyev | L. Hensley | S. Bavari | O. Dolnik | S. Becker | S. Nichol | J. R. Brister | J. Patterson | E. Mühlberger | J. Pawęska | Karl M. Johnson | R. Swanepoel | E. Leroy | J. Towner | G. Groen | A. Honko | V. Wahl-Jensen | T. Hoenen | Jean L. Patterson | A. Bukreyev | Hans-Dieter Klenk | Pierre Formenty | Sheli R. Radoshitzky | Gustavo Palacios | Robert Swanepoel | Kelly L. Warfield | Jonathan S. Towner | Sven Enterlein | Elke Mühlberger | Yīmíng Bào | Steven Bradfute | Kristina Brauburger | J. Rodney Brister | Alexander A. Bukreyev | Yíngyún Caì | Olga Dolnik | Jean-Paul Gonzalez | Alexander N. Freiberg | Anna N. Honko | Georgy M. Ignatyev | Gary Kobinger | Matthew G. Lackemeyer | Eric M. Leroy | Sergey V. Netesov | Janusz T. Paweska | Louise Pitt | Elena I. Ryabchikova | Aleksandr M. Shestopalov | Nancy J. Sullivan | Guido Groen | Viktor E. Volchkov | Valentina A. Volchkova | Victoria Wahl-Jensen | G. van der Groen | S. Smither | E. Ryabchikova | S. Netesov | M. Lever | Travis K Warren | J. Rodney Brister | L. Pitt | Sven Enterlein | Kristina Brauburger | K. Johnson | A. Shestopalov | Sergewy V. Netesov | S. V. Netesov

[1]  S. Zaki,et al.  Inhibition of IRF-3 Activation by VP35 Is Critical for the High Level of Virulence of Ebola Virus , 2008, Journal of Virology.

[2]  T. Noda,et al.  Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell Culture , 2005, Journal of Virology.

[3]  V. Volchkov,et al.  VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. , 2011, The Journal of infectious diseases.

[4]  V. Volchkov,et al.  Role of Ebola Virus VP30 in Transcription Reinitiation , 2008, Journal of Virology.

[5]  J. Kuhn,et al.  Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. , 2011, Antiviral research.

[6]  S. Nichol,et al.  Reverse Genetic Generation of Recombinant Zaire Ebola Viruses Containing Disrupted IRF-3 Inhibitory Domains Results in Attenuated Virus Growth In Vitro and Higher Levels of IRF-3 Activation without Inhibiting Viral Transcription or Replication , 2006, Journal of Virology.

[7]  R. Koup,et al.  The Lack of Maturation of Ebola Virus-Infected Dendritic Cells Results from the Cooperative Effect of at Least Two Viral Domains , 2013, Journal of Virology.

[8]  O. Dolnik,et al.  Assembly of the Marburg virus envelope , 2013, Cellular microbiology.

[9]  G. Neumann,et al.  Molecular Determinants of Ebola Virus Virulence in Mice , 2006, PLoS pathogens.

[10]  Yiming Bao,et al.  Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae , 2012, Archives of Virology.

[11]  V. Volchkov,et al.  Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication. , 2011, The Journal of infectious diseases.

[12]  Jens H. Kuhn,et al.  Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations , 2010, Archives of Virology.

[13]  M. V. Regenmortel,et al.  Should all other biologists follow the lead of virologists and stop italicizing the names of living organisms? A proposal , 2009 .

[14]  Thomas Hoenen,et al.  Inclusion Bodies Are a Site of Ebolavirus Replication , 2012, Journal of Virology.

[15]  H. Ebihara,et al.  The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo , 2012, PLoS pathogens.

[16]  V. Volchkov,et al.  Role of VP30 phosphorylation in the Ebola virus replication cycle. , 2011, The Journal of infectious diseases.

[17]  S. Günther,et al.  Establishment of Fruit Bat Cells (Rousettus aegyptiacus) as a Model System for the Investigation of Filoviral Infection , 2010, PLoS neglected tropical diseases.

[18]  S. Nichol,et al.  Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. , 2006, Virus research.

[19]  V. Volchkov,et al.  Recovery of Infectious Ebola Virus from Complementary DNA: RNA Editing of the GP Gene and Viral Cytotoxicity , 2001, Science.

[20]  V. Krähling,et al.  Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. , 2011, The Journal of infectious diseases.

[21]  A. Takada,et al.  A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals. , 2013, Antiviral research.

[22]  L. A. Ball,et al.  Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2008) , 2009, Archives of Virology.

[23]  G. Neumann,et al.  Rescue of Ebola virus from cDNA using heterologous support proteins. , 2004, Virus research.

[24]  V. Volchkov,et al.  Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. , 2011, The Journal of infectious diseases.

[25]  J. Maniloff,et al.  Virus taxonomy : eighth report of the International Committee on Taxonomy of Viruses , 2005 .

[26]  V. Volchkov,et al.  Rescue of Recombinant Marburg Virus from cDNA Is Dependent on Nucleocapsid Protein VP30 , 2006, Journal of Virology.

[27]  H. Feldmann,et al.  An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication , 2013, PLoS pathogens.

[28]  C. Goldsmith,et al.  Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. , 2005, Virology.

[29]  Yiming Bao,et al.  Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae , 2013, Archives of Virology.

[30]  G. Neumann,et al.  In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. , 2007, The Journal of infectious diseases.

[31]  V. Krähling,et al.  The Marburg Virus 3′ Noncoding Region Structurally and Functionally Differs from That of Ebola Virus , 2009, Journal of Virology.

[32]  V. Volchkov,et al.  Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs , 2010, Journal of Virology.

[33]  Shinji Watanabe,et al.  Reverse Genetics Demonstrates that Proteolytic Processing of the Ebola Virus Glycoprotein Is Not Essential for Replication in Cell Culture , 2002, Journal of Virology.